| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |